This product is indicated for keratohelcosis and corneal injury due to various causes, corneal bum caused by acid or alkali, bullous keratitis, neuroparalytic keratitis, cornea and conjunctivae degenernation.
Promotes tear secretion in patients with dry eyes. Indicated for reduced tear secretion caused by ocular inflammation associated with keratoconjunctivitis sicca.
Sjogren’s syndrome, Stevens-Johnson syndrome, dry eye syndrome and other endogenous diseases; post-operative and drug-induced diseases, injury, discomfort caused by wearing contact lens and other exogenous diseases.
As an adjuvant therapy for cornea protection, this product is indicated for dry eye disease caused by various reasons (such as Sjogren’s syndrome, neuroparalytic keratitis, and exposure keratitis), conjunctiva and corneal irritations caused by the lack of tear film protection.
Meticulous Attention to Details Ensures Quality Products
The Qipan Mountain Factory of Sinqi Ophthalmic Medications was put into production in 2014. It was designed in accordance with US FDA and EU GMP standards and was jointly founded by world-class design team, equipment suppliers and construction companies. It has production lines for calf blood extractives, single-dose eye drops, multi-dose eye drops, ophthalmic gel, ophthalmic solution and inner packaging materials for ophthalmic medications etc.
▲Calf blood extraction line▲
▲Single dose eye drops production line▲
▲Multi-dose eye drops production line▲
▲Eye gel production line▲
▲Eye solution production line▲